FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer
- FDA 近 90 天出现 6 次
- 上一次：同一天稍早 · FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar
发生了什么
The U.S. Food and Drug Administration today approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule.
摘要按规则整理自下方来源原文
为什么在扩散
时间线
- FDA Press Releases 最先出现FDA Press Releases
- Hacker News 出现讨论Hacker News